Mutations that alter the arginine (R) residue at the position 176 or 179 would render the protein resistant to proteolytic cleavage and lead to increased serum levels of FGF23 and its activity, resulting in hypophosphatemia (61,71,72). This evidence concerns the gene FGF23 and hypophosphatemia.